Advances in clinical chemistry, 2020, Vol.97, p.117-140
2020
Volltextzugriff (PDF)
Details
- Autor(en) / Beteiligte
- Titel
- Long non-coding RNA HOTAIR in cervical cancer: Molecular marker, mechanistic insight, and therapeutic target
- Ist Teil von
- Advances in clinical chemistry, 2020, Vol.97, p.117-140
- Ort / Verlag
- United States
- Erscheinungsjahr
- 2020
- Quelle
- MEDLINE
- Beschreibungen/Notizen
- Cervical cancer is a common gynecologic malignant tumor with high mortality. HOX transcript antisense RNA (HOTAIR), a trans-acting long non-coding RNA (lncRNA) containing six exons in humans, is transcribed from the antisense strand of homeobox gene C cluster. This lncRNA serves as a modular scaffold for gene silencing and protein ubiquitination. In patients with cervical cancer, elevated HOTAIR levels are significantly associated with poor prognosis. HOTAIR plays an oncogenic role in cervical cancer by promoting cell proliferation, migration, invasion and autophagy, inhibiting cell apoptosis, stimulating angiogenesis, accelerating cell cycle progression, and inducing epithelial-mesenchymal transition. Moreover, blockade of HOTAIR by artesunate or propofol shows promise for further development of this lncRNA as a potential therapeutic target in cervical cancer. In this review, we summarized the latest advances regarding the role of HOTAIR in cervical cancer with an emphasis on its diagnostic and prognostic values.
- Sprache
- Englisch
- Identifikatoren
- eISSN: 2162-9471DOI: 10.1016/bs.acc.2019.12.004Titel-ID: cdi_proquest_miscellaneous_2406579779
- Format
- –
- Schlagworte
- Antineoplastic Agents - pharmacology, Biomarkers, Tumor - antagonists & inhibitors, Biomarkers, Tumor - genetics, Biomarkers, Tumor - metabolism, Female, Humans, RNA, Long Noncoding - antagonists & inhibitors, RNA, Long Noncoding - genetics, RNA, Long Noncoding - metabolism, Uterine Cervical Neoplasms - drug therapy, Uterine Cervical Neoplasms - genetics, Uterine Cervical Neoplasms - metabolism